IP Library Patent Application 10587831
Patent Application
App. No. 10/587,831

Test System and Method for the Detection of Analytes

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/587,831
Abstract

The invention relates to analytical test systems and analytical methods, in which molecular switches are used for the qualitative and quantitative determination of analytes in a sample, which have a broad application by means of a selection of the molecular switch suitable for the analyte. The molecular switch comprises a probe, preferably a nucleic acid or a nucleic acid derivative, coupled to a catalytic component, preferably an enzyme. The analyte induces a conformation change in the probe, which alters the accessibility for a substrate in the probe to catalytic components and the change in substrate turnover, corresponding to the change in catalytic activity, is measured.

Claims (16)

1 . An analytical test system comprising a molecular switch comprising a probe and a catalytic component.

2 . The system as claimed in claim 1 , wherein the probe is conjugated to the catalytic component either directly or by way of a coupling component.

3 . The system as claimed in claim 2 , wherein the catalytic activity of the molecular switch is changed when an analyte contacts the probe.

4 . The system as claimed in claim 3 , wherein the change in the catalytic activity of the molecular switch is due to a conformational change in the probe which is elicited by the analyte.

5 . The system as claimed in claim 1 , wherein the probe or a constituent thereof is a nucleic acid or a nucleic acid derivative.

6 . The system as claimed in claim 5 , wherein the nucleic acid is a ribonucleic acid, a deoxyribonucleic acid, a peptide nucleic acid, or a locked nucleic acid.

7 . The system as claimed in claim 5 , wherein the nucleic acid or the nucleic acid derivative is present in hybridized form.

8 . The system as claimed in claim 1 , wherein the probe or a constituent thereof is an oligonucleotide.

9 . The system as claimed in claim 8 , wherein the oligonucleotide exhibits an intramolecular hybridization.

10 . The system as claimed in claim 1 , wherein the catalytic component or a constituent thereof is an enzyme, an antibody, a catalytically active nucleic acids or a catalytically active nucleic acid derivative.

11 . The system as claimed in claim 10 , wherein the catalytically active nucleic acid or the catalytically active nucleic acid derivative is a ribonucleic acid, a deoxyribonucleic acid, a peptide nucleic acid, or a locked nucleic acid.

12 . The system as claimed in claim 10 , wherein the catalytic component or a constituent thereof is an enzyme.

13 . A method for determining the presence or concentration of an analyte in a sample, comprising contacting a molecular switch with a sample and measuring the activity of the molecular switch to thereby determine the presence or concentration of the analyte.

14 .- 15 . (canceled)

16 . The method of claim 13 , wherein the analyte is a nucleic acid or a nucleic acid derivative.

17 . A molecular switch comprising a probe and a catalytic component.

Assignments (2)
CHANGE OF NAME Recorded Feb 26, 2009
From: DADE BEHRING MARBURG GMBH
To: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Reel/Frame 022309/0627 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2006
From: VITZTHUM, FRANK
To: DADE BEHRING MARBURG GMBH
Reel/Frame 018152/0786 →